Orexigen Therapeutics (OREX)

Add to Watchlists
Create an Alert
5.30 -0.08  -1.49% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
OREX Price Chart
View All Events

OREX Events

Date Type Description
Mar 12 Misc Orexigen Therapeutics, Inc. Q4 2013 Earning Conference Call
Mar 12 Earnings Orexigen Therapeutics, Inc. Q4 2013 Earning Result. Estimate: -0.19.
Nov 12 Misc Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference Call
Nov 12 Earnings Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Earnings Release. Estimate: -0.17.
Aug 06 Misc Q2 2013 Orexigen Therapeutics, Inc. Earnings Conference Call
Aug 06 Earnings Second Quarter 2013 Financial Results. Estimate: -0.19.
Jun 05 Misc AGM Event for Orexigen Therapeutics Inc
May 08 Misc Q1 2013 Orexigen Therapeutics, Inc. Earnings Conference Call
May 08 Earnings Q1 2013 Earnings Results. Estimate: -0.34.
View All Performance Charts

OREX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Orexigen Therapeutics is down 14.52% over the last year vs S&P 500 Total Return up 23.54%, Takeda Pharmaceutical down 14.52%, and Vivus down 55.96%.

Get Quote for

PDF Report for OREX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download OREX Pro Report PDF
Advertisement

Portfolio Strategies Featuring OREX

Did Orexigen Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OREX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Orexigen Therapeutics, Inc., is a biopharmaceutical company. The Company is engaged in development of pharmaceutical product candidates for the treatment of obesity. Its product candidate includes: Contrave & Empatic.

Recent Quotes

Symbol Price Chg Chg % Market Cap
OREX 5.30 -0.08 -1.49% 556.34M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.